{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T16:40:22Z","timestamp":1732034422910},"reference-count":58,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Apheresis"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:p>A functional deficiency of ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif), a von\u2010Willebrand factor (VWF) cleaving protease, is central to the pathogenesis of congenital and acquired thrombotic thrombocytopenic purpura (TTP). ADAMTS13 testing has evolved from assays that required long denaturation and incubation times to ones that employ a modified recombinant VWF with improved standardization and turn around times. While plasma exchange is a mainstay in the treatment of TTP, increased use of rituximab, an antibody against CD20, has proved helpful in the treatment of patients with exacerbations and relapses. The next generation of drugs focuses on using recombinant ADAMTS13 and molecules that block the interaction of VWF and platelets to prevent thrombotic microangiopathy. The increased awareness and availability of ADAMTS13 testing has also made it possible to detect atypical presentations of TTP such as patients with macrovascular neurological symptoms without accompanying hematological findings as well as help diagnose other causes of thrombotic microangiopathies e.g. atypical hemolytic uremic syndrome. The use of ADAMTS13 testing in the management of TTP should continue to grow especially with newer assays with greater sensitivity, reproducibility, and timelier availability. J. Clin. Apheresis 28:30\u201335, 2013. \u00a9 2013 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/jca.21264","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T18:22:51Z","timestamp":1361298171000},"page":"30-35","source":"Crossref","is-referenced-by-count":10,"title":["Thrombotic thrombocytopenic purpura\u2014what is new?"],"prefix":"10.1002","volume":"28","author":[{"given":"Neil","family":"Shah","sequence":"first","affiliation":[{"name":"Division of Transfusion Medicine and Hemostasis Department of Pathology UT Southwestern Medical Center Dallas Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Sarode","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine and Hemostasis Department of Pathology UT Southwestern Medical Center Dallas Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2004.1.407"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.3.592.592"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392203"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392202"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100515200"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-009-0476-1"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03761.x"},{"key":"e_1_2_5_11_1","first-page":"127","article-title":"Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura","volume":"6","author":"Franchini M","year":"2008","journal-title":"Blood Transf"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1248727"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.9.3097"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614780"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-002-0502-3"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614779"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05420.x"},{"key":"e_1_2_5_18_1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1160\/TH06-03-0166","article-title":"Comparison of FRETS\u2010VWF73 to full\u2010lengthVWF as a substrate forADAMTS13 activity measurement in human plasma samples","volume":"95","author":"Agn\u00e8sVeyradier MD","year":"2006","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01904.x"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01758.x"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07107.x"},{"key":"e_1_2_5_22_1","first-page":"69","article-title":"Development of a novel ADAMTS13 activity assay for diagnosis of TMA and criteria for judgment of platelet transfusion","volume":"55","author":"Hiura H","year":"2007","journal-title":"Rinsho Byori"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.06210"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00914.x"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04119.x"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M301385200"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1616"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4490"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.042945"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06688.x"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03099.x"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00879.x"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02438.x"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2096"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.alc.0000192326.08931.cb"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1087"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02514.x"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0166"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1765"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0193"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05217.x"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09167.x"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.00626.x"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02653.x"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11739"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-4035"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-006064"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20182"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21216"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-1141-x"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1179\/102453312X13336169155178"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-341131"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11709"},{"key":"e_1_2_5_54_1","unstructured":"SadlerJE.Low dose rituximab in thrombotic thrombocytopenic purpura\u2014full text view\u2014Clinicaltrials.gov. Available at:http:\/\/Clinicaltrials.gov\/ct2\/show\/NCT01554514. Accessed July 5 2012."},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1397"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2011.08.004"},{"key":"e_1_2_5_57_1","first-page":"309","article-title":"Hemolytic uremic syndrome in children\u2014a concise review","volume":"5","author":"Ogundele MO","year":"2010","journal-title":"J Pediatr Infect Dis"},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1262890"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09032.x"}],"container-title":["Journal of Clinical Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjca.21264","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jca.21264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T01:28:06Z","timestamp":1694482086000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jca.21264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1002\/jca.21264"],"URL":"https:\/\/doi.org\/10.1002\/jca.21264","archive":["Portico"],"relation":{},"ISSN":["0733-2459","1098-1101"],"issn-type":[{"value":"0733-2459","type":"print"},{"value":"1098-1101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}